Gilead Sciences Inc
F:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
F:GIS
|
US |
|
B
|
Bank of America Corp
XMUN:NCB
|
US |
|
Scentre Group
ASX:SCG
|
AU |
|
S
|
SGL Carbon SE
DUS:SGL
|
DE |
Wall St Price Targets
GIS Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for GIS is 137.93 EUR with a low forecast of 105.27 EUR and a high forecast of 161.46 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIS's stock price target?
Price Target
137.93
EUR
According to Wall Street analysts, the average 1-year price target for GIS is 137.93 EUR with a low forecast of 105.27 EUR and a high forecast of 161.46 EUR.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Gilead Sciences Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 13%.
What is the Pre-Tax Income forecast for Gilead Sciences Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 16%.
